A5012165354- Lung Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Lung Cancer Treatments and Mutations
- Nutrition and Health in Aging
- Sarcoma Diagnosis and Treatment
- Cancer Cells and Metastasis
- Medical Imaging and Pathology Studies
- Multiple Sclerosis Research Studies
- Radiopharmaceutical Chemistry and Applications
- Cancer Diagnosis and Treatment
- Bone health and treatments
- Sphingolipid Metabolism and Signaling
- Autoimmune and Inflammatory Disorders Research
- Cancer Genomics and Diagnostics
- Gastrointestinal Tumor Research and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Research and Treatments
- Prostate Cancer Treatment and Research
- Oral health in cancer treatment
- Gastric Cancer Management and Outcomes
- Bacteriophages and microbial interactions
Ospedale San Luigi Gonzaga
2023-2025
University of Turin
2023-2025
Ospedale degli Infermi
2024
Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli
2024
Candiolo Cancer Institute
2021-2023
Istituti di Ricovero e Cura a Carattere Scientifico
2020
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2020
Vita-Salute San Raffaele University
2020
e17111 Background: Androgen deprivation therapy (ADT) increases the risk of fractures. The addition an androgen receptor pathway inhibitor (ARPI) to ADT (MAB) has shown improve outcomes compared monotherapy in patients (pts) with metastatic castration-resistant PC (mCRPC), non-mCRPC (nmCRPC), hormone-sensitive (mHSPC), high-risk localized disease and biochemical relapse. There is no definitive evidence whether MAB fractures alone. Methods: We conducted a systematic review all clinical trials...
Abstract Background Inflammation in non‐small cell lung cancer (NSCLC) may impair the response to immune checkpoint inhibitors (ICIs) and can be indicated by peripheral blood inflammatory indexes. 2‐deoxy‐2‐[ 18 F]fluoro‐D‐glucose positron emission tomography/computed tomography ([ F] FDG‐PET/CT) used as a marker of inflammation measuring glucose metabolism different colonic sites. Methods This retrospective analysis aimed investigate correlation between [ FDGPET/CT SUV ratio six...
Introduction Immunotherapy (IO) has established a new milestone in lung cancer treatment. Several registrational studies have approved immune checkpoint inhibitors (ICIs) different settings, including the metastatic nonsmall cell (NSCLC). As wellknown, responders are just certain proportion of patients, therefore their selection by using predictive factors stood out as crucial issue to address tailoring patientcentered care.
Importance Gastrointestinal stromal tumor (GIST) follow-up is recommended by international guidelines, but data on the role of in patients with low relapse risk are missing. For these patients, potential benefit anticipating recurrence detection should be weighed against psychological burden and radiologic examination loads terms costs radiation exposure. Objective To evaluate outcomes guideline-based low-risk GIST. Design, Setting, Participants This multi-institutional retrospective cohort...
Background: Fingolimod (FTY) is an effective second-line drug for relapsing-remitting multiple sclerosis, with ~50% patients showing no evidence of disease activity (NEDA) after 2 years. Nonetheless, the early identification non-responders extremely important, to promptly address them more aggressive drugs. Objectives: This cohort study evaluates FTY medium-term effectiveness, searching markers treatment failure. Patients and methods: Three hundred eighty starting were enrolled classified...
<title>Abstract</title> Purpose Approximately a 70% of lung cancer (LC) patients experience malnutrition. Therefore, rapid and functional nutritional assessment is needed. Several screening instruments are available for clinical use. This study aimed to compare the Nutritional Risk Screening − 2002 (NRS-2002) Malnutrition Tool (MST) assess malnutrition in LC patients. Methods MST, NRS-2002, quality life (QoL) Handgrip Test were performed at baseline (T0), day 30th (T1) 90th (T2). The...
During last years, lung cancer treatment has rapidly changed thanks to novel drugs, such as immunotherapy and target therapy. Hence, an improvement of life expectancy, notwithstanding with a higher infectious risk. This is probably due many factors, longer survival immunosuppression; furthermore, drugs could increase risk different biologic mechanisms. However, correlation between infections not been completely clear, although lately increasingly described. Salmonella enterica spp...
11571 Background: Despite surgically resectable pulmonary metastases may lead to cure patients with B-STS (Chudgar NP 2017), a substantial proportion of will eventually relapse. Presently, patient selection is based on unique organ involvement, number metastases, interval between previous surgery and progression or We assessed the impact anatomical site metastasis into lung (as if pleural might ease further tumor spreading) nodule growth rate as additional predictive/prognostic factors...